GALT - Spark Newswire

7 minute read

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday

July 29, 5:55 AM

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.

AMPS

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

July 27, 6:06 PM

Gainers

ALVR

4 minute read

62 Biggest Movers From Yesterday

By Lisa Levin

June 2, 6:10 AM

Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.

AFRM

1 minute read

HC Wainwright & Co. Maintains Buy on Galectin Therapeutics, Lowers Price Target to $11

By Benzinga Newsdesk

May 17, 7:17 AM

HC Wainwright & Co. analyst Ed Arce maintains Galectin Therapeutics (NASDAQ:GALT) with a Buy and lowers the price target from $14 to $11.

GALT

1 minute read

Recap: Galectin Therapeutics Q1 Earnings

By Benzinga Insights

May 16, 8:29 AM

Galectin Therapeutics (NASDAQ:GALT) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

GALT

1 minute read

Galectin Therapeutics Q1 EPS $(0.17) Down From $(0.11) YoY

By Benzinga Newsdesk

May 16, 8:09 AM

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.17) per share. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year.

GALT